Last updated on April 2019

FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

Brief description of study

Preliminary data suggests that FOLFOX-A may have equal or superior activity as compared to FOLFIRINOX for patients with metastatic pancreatic cancer and appears to be better tolerated with the ability to administer at least 10 cycles of therapy. Investigators therefore will evaluate FOLFOX-A in a phase II study for patient with locally advanced pancreatic cancer.

Detailed Study Description

See summary above

Clinical Study Identifier: NCT02578732

Find a site near you

Start Over

Rhode Island Hospital and The Miriam Hospital

Providence, RI United States
  Connect »